USE OF CARBAMIC ACID COMPOUND FOR PREVENTION OR TREATMENT OF FIBROMYALGIA OR FUNCTIONAL SYNDROME ASSOCIATED WITH FIBROMYALGIA Russian patent published in 2021 - IPC A61K31/16 A61K31/41 A61P21/00 A61P25/00 

FIELD: medicine.

SUBSTANCE: group of inventions relates to the field of medicine, namely, to a method for the prevention or treatment of fibromyalgia or associated functional symptoms of fibromyalgia in a subject, including the injection of therapeutically effective amount of (R)-1-(2-chlorophenyl)-2-tetrazole-2-yl)ethyl ether of carbamic acid, or its pharmaceutically acceptable salt to a subject, where the associated functional symptoms of fibromyalgia are selected from a group consisting of body temperature disorder, irritable bowel syndrome, symptoms of Sikka, hyperhidrosis (increased sweating), dizziness, tremor, dyspnea, arrhythmias, paresthesia and chronic fatigue, as well as to the use of(R)-1-(2-chlorophenyl)-2-tetrazole-2-yl)ethyl ether of carbamic acid, or its pharmaceutically acceptable salt for the prevention or treatment of fibromyalgia or associated functional symptoms of fibromyalgia.

EFFECT: group of inventions provides for effective prevention and treatment of fibromyalgia and associated functional symptoms of fibromyalgia, where the associated functional symptoms of fibromyalgia are selected from a group consisting of body temperature disorder, irritable bowel syndrome, symptoms of Sikka, hyperhidrosis (increased sweating), dizziness, tremor, dyspnea, arrhythmias, paresthesia and chronic fatigue.

8 cl, 2 dwg, 1 tbl, 1 ex